Fig. 1From: Pharmacodynamic mechanisms behind a refractory state in inflammatory bowel diseaseClinical outcome of ulcerative colitis (UC) and Crohn’s disease (CD) with non-response to biological treatments. Conventional therapy includes 5-ASA local/systemic, corticosteroid local/systemic, immunomodulator (azathioprine or methotrexate)Back to article page